News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Eli Avisar

Articles by Eli Avisar

5 Predictors of Axillary Complete Pathologic Response in Hormone Receptor–Positive, HER2-Negative, Clinically Node-Positive Breast Cancer

5 Predictors of Axillary Complete Pathologic Response in Hormone Receptor–Positive, HER2-Negative, Clinically Node-Positive Breast Cancer

ByAnshumi Desai,Youley Tjendra,Eli Avisar

August 29th 2024

42 Transitional Lymphedema: Understanding the Temporal Dynamics Post-Axillary Surgery

ByAnshumi Desai,Victoria Dahl,Carolina Padilla,Seraphina Choi,Eli Avisar

May 29th 2024

Latest Updated Articles

Trending on CancerNetwork

ASH 2025: The Top 10 Takeaways for Hematologic Oncology Care

How Should a Patient With Multiple Myeloma Manage Talquetamab’s Toxicity?

QOL Improvement in Breast Cancer Noted With YES System

What is Cevostamab’s Mechanism of Action in Multiple Myeloma?

FDA Approves Niraparib Regimen in BRCA2+ Metastatic CSPC

© 2025 MJH Life Sciences^®

All rights reserved.